154 related articles for article (PubMed ID: 34482237)
1. Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals.
Nam G; Suh JM; Yi Y; Lim MH
J Inorg Biochem; 2021 Nov; 224():111592. PubMed ID: 34482237
[TBL] [Abstract][Full Text] [Related]
2. Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer's Disease.
Han J; Lee HJ; Kim KY; Lee SJC; Suh JM; Cho J; Chae J; Lim MH
ACS Chem Neurosci; 2018 Apr; 9(4):800-808. PubMed ID: 29283241
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
4. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
5. Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.
Beck MW; Derrick JS; Kerr RA; Oh SB; Cho WJ; Lee SJ; Ji Y; Han J; Tehrani ZA; Suh N; Kim S; Larsen SD; Kim KS; Lee JY; Ruotolo BT; Lim MH
Nat Commun; 2016 Oct; 7():13115. PubMed ID: 27734843
[TBL] [Abstract][Full Text] [Related]
6. Minimalistic Principles for Designing Small Molecules with Multiple Reactivities against Pathological Factors in Dementia.
Kim M; Kang J; Lee M; Han J; Nam G; Tak E; Kim MS; Lee HJ; Nam E; Park J; Oh SJ; Lee JY; Lee JY; Baik MH; Lim MH
J Am Chem Soc; 2020 May; 142(18):8183-8193. PubMed ID: 32233474
[TBL] [Abstract][Full Text] [Related]
7. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
8. Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.
Beck MW; Derrick JS; Suh JM; Kim M; Korshavn KJ; Kerr RA; Cho WJ; Larsen SD; Ruotolo BT; Ramamoorthy A; Lim MH
ChemMedChem; 2017 Nov; 12(22):1828-1838. PubMed ID: 28990338
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
[TBL] [Abstract][Full Text] [Related]
10. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
12. A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.
Savelieff MG; Liu Y; Senthamarai RR; Korshavn KJ; Lee HJ; Ramamoorthy A; Lim MH
Chem Commun (Camb); 2014 May; 50(40):5301-3. PubMed ID: 24326305
[TBL] [Abstract][Full Text] [Related]
13. Structural and Mechanistic Insights into Development of Chemical Tools to Control Individual and Inter-Related Pathological Features in Alzheimer's Disease.
Lee HJ; Korshavn KJ; Nam Y; Kang J; Paul TJ; Kerr RA; Youn IS; Ozbil M; Kim KS; Ruotolo BT; Prabhakar R; Ramamoorthy A; Lim MH
Chemistry; 2017 Feb; 23(11):2706-2715. PubMed ID: 28004889
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
Nadal RC; Rigby SE; Viles JH
Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
[TBL] [Abstract][Full Text] [Related]
15. Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity.
Wärmländer SKTS; Österlund N; Wallin C; Wu J; Luo J; Tiiman A; Jarvet J; Gräslund A
J Biol Inorg Chem; 2019 Dec; 24(8):1189-1196. PubMed ID: 31562546
[TBL] [Abstract][Full Text] [Related]
16. Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.
Caballero AB; Terol-Ordaz L; Espargaró A; Vázquez G; Nicolás E; Sabaté R; Gamez P
Chemistry; 2016 May; 22(21):7268-80. PubMed ID: 27071336
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
19. Cu
Stefaniak E; Bal W
Inorg Chem; 2019 Oct; 58(20):13561-13577. PubMed ID: 31304745
[TBL] [Abstract][Full Text] [Related]
20. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
